As for CD37, an independent study, published in 2019, on the brain metastasis of non-small cell lung cancer identified CD37 as an effective biomarker for lung cancer brain metastasis [48], consistent with our prediction of CD37 as a potential biomarker for non-small cell lung cancer-associated cell subgrouping. This evidence concerns the gene CD37 and lung cancer.